BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 24632066)

  • 21. In vitro characterization of the metabolic pathways and cytochrome P450 inhibition and induction potential of BMS-690514, an ErbB/vascular endothelial growth factor receptor inhibitor.
    Hong H; Su H; Ma L; Yao M; Iyer RA; Humphreys WG; Christopher LJ
    Drug Metab Dispos; 2011 Sep; 39(9):1658-67. PubMed ID: 21673131
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validated liquid chromatography-tandem mass spectrometry method for determination of totally nine probe metabolites of cytochrome P450 enzymes and UDP-glucuronosyltransferases.
    Lee JT; Pao LH; Hsiong CH; Huang PW; Shih TY; Yoa-Pu Hu O
    Talanta; 2013 Mar; 106():220-8. PubMed ID: 23598120
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of honokiol on cytochrome P450 and UDP-glucuronosyltransferase enzyme activities in human liver microsomes.
    Jeong HU; Kong TY; Kwon SS; Hong SW; Yeon SH; Choi JH; Lee JY; Cho YY; Lee HS
    Molecules; 2013 Sep; 18(9):10681-93. PubMed ID: 24005963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In Vitro Interaction of AB-FUBINACA with Human Cytochrome P450, UDP-Glucuronosyltransferase Enzymes and Drug Transporters.
    Kim S; Kim DK; Shin Y; Jeon JH; Song IS; Lee HS
    Molecules; 2020 Oct; 25(19):. PubMed ID: 33050066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro inhibitory mechanisms and molecular docking of 1'-S-1'-acetoxychavicol acetate on human cytochrome P450 enzymes.
    Haque AKMM; Leong KH; Lo YL; Awang K; Nagoor NH
    Phytomedicine; 2017 Jul; 31():1-9. PubMed ID: 28606510
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification and characterization of in vitro inhibitors against UDP-glucuronosyltransferase 1A1 in uva-ursi extracts and evaluation of in vivo uva-ursi-drug interactions.
    Park JB; Kim D; Min JS; Jeong S; Cho DY; Zheng YF; Yoon KD; Bae SK
    Food Chem Toxicol; 2018 Oct; 120():651-661. PubMed ID: 30075316
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug interaction potential of soy extract and Panax ginseng.
    Anderson GD; Rosito G; Mohustsy MA; Elmer GW
    J Clin Pharmacol; 2003 Jun; 43(6):643-8. PubMed ID: 12817527
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of human drug-metabolising cytochrome P450 and UDP-glucuronosyltransferase enzyme activities in vitro by uremic toxins.
    Barnes KJ; Rowland A; Polasek TM; Miners JO
    Eur J Clin Pharmacol; 2014 Sep; 70(9):1097-106. PubMed ID: 24954688
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure-inhibition relationship of ginsenosides towards UDP-glucuronosyltransferases (UGTs).
    Fang ZZ; Cao YF; Hu CM; Hong M; Sun XY; Ge GB; Liu Y; Zhang YY; Yang L; Sun HZ
    Toxicol Appl Pharmacol; 2013 Mar; 267(2):149-54. PubMed ID: 23306165
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibitory Effects of Selected Antituberculosis Drugs on Common Human Hepatic Cytochrome P450 and UDP-glucuronosyltransferase Enzymes.
    Cao L; Greenblatt DJ; Kwara A
    Drug Metab Dispos; 2017 Sep; 45(9):1035-1043. PubMed ID: 28663285
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A sensitive and high-throughput LC-MS/MS method for inhibition assay of seven major cytochrome P450s in human liver microsomes using an in vitro cocktail of probe substrates.
    Liu LY; Han YL; Zhu JH; Yu Q; Yang QJ; Lu J; Guo C
    Biomed Chromatogr; 2015 Mar; 29(3):437-44. PubMed ID: 25098274
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigation on the metabolic characteristics of isobavachin in Psoralea corylifolia L. (Bu-gu-zhi) and its potential inhibition against human cytochrome P450s and UDP-glucuronosyltransferases.
    Xing H; Yang J; Ren K; Qin Z; Wang P; Zhang X; Yao Z; Gonzalez FJ; Yao X
    J Pharm Pharmacol; 2020 Dec; 72(12):1865-1878. PubMed ID: 32750744
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In Vitro Inhibitory Effects of APINACA on Human Major Cytochrome P450, UDP-Glucuronosyltransferase Enzymes, and Drug Transporters.
    Kim S; Choi WG; Kwon M; Lee S; Cho YY; Lee JY; Kang HC; Song IS; Lee HS
    Molecules; 2019 Aug; 24(16):. PubMed ID: 31430908
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and validation of an in vitro, seven-in-one human cytochrome P450 assay for evaluation of both direct and time-dependent inhibition.
    Dahlinger D; Duechting S; Nuecken D; Sydow K; Fuhr U; Frechen S
    J Pharmacol Toxicol Methods; 2016; 77():66-75. PubMed ID: 26528794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro assay of six UDP-glucuronosyltransferase isoforms in human liver microsomes, using cocktails of probe substrates and liquid chromatography-tandem mass spectrometry.
    Seo KA; Kim HJ; Jeong ES; Abdalla N; Choi CS; Kim DH; Shin JG
    Drug Metab Dispos; 2014 Nov; 42(11):1803-10. PubMed ID: 25122565
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In Vitro Characterization of Ertugliflozin Metabolism by UDP-Glucuronosyltransferase and Cytochrome P450 Enzymes.
    Lapham K; Callegari E; Cianfrogna J; Lin J; Niosi M; Orozco CC; Sharma R; Goosen TC
    Drug Metab Dispos; 2020 Dec; 48(12):1350-1363. PubMed ID: 33020067
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design and optimization of the cocktail assay for rapid assessment of the activity of UGT enzymes in human and rat liver microsomes.
    Chen A; Zhou X; Cheng Y; Tang S; Liu M; Wang X
    Toxicol Lett; 2018 Oct; 295():379-389. PubMed ID: 30036684
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro evaluation of the interaction potential of irosustat with drug-metabolizing enzymes.
    Ventura V; Solà J; Peraire C; Brée F; Obach R
    Drug Metab Dispos; 2012 Jul; 40(7):1268-78. PubMed ID: 22451700
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In Vitro Inhibition of Human UDP-Glucuronosyl-Transferase (UGT) Isoforms by Astaxanthin, β-Cryptoxanthin, Canthaxanthin, Lutein, and Zeaxanthin: Prediction of in Vivo Dietary Supplement-Drug Interactions.
    Zheng YF; Min JS; Kim D; Park JB; Choi SW; Lee ES; Na K; Bae SK
    Molecules; 2016 Aug; 21(8):. PubMed ID: 27529203
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mangifera indica L. extract and mangiferin modulate cytochrome P450 and UDP-glucuronosyltransferase enzymes in primary cultures of human hepatocytes.
    Rodeiro I; José Gómez-Lechón M; Perez G; Hernandez I; Herrera JA; Delgado R; Castell JV; Teresa Donato M
    Phytother Res; 2013 May; 27(5):745-52. PubMed ID: 22815239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.